Clinical Trial of tipifarnib in HRAS Positive Advanced
Squamous Cell Cancer
A clinical trial of an investigational new drug, tipifarnib, is currently enrolling adults with HRAS Positive Advanced Squamous Cell Cancer
If you or someone you love would like to be considered for this clinical trial, please complete the sign-up form. If you qualify, a nurse case manager will contact you.
This content is approved for residents of the United States only.